Sulfacetamide Sodium, Sulfur NDC 52187-547

NDC codes

FDA NDC Directory

Product NDC (as listed)52187-547Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52187-0547Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52187-547-02	52187054702	57 g in 1 BOTTLE, PLASTIC (52187-547-02)Marketed from Feb 28, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfacetamide Sodium, Sulfur
Generic name (nonproprietary): sulfacetamide sodium, sulfur
Active ingredients: Sulfacetamide sodium — 98 mg/gSulfur — 48 mg/g
Dosage form: Cream
Route: Topical
Labeler: KMM Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Feb 28, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 52187-547_d916e437-366b-c00d-e053-2995a90ace0cSPL ID d916e437-366b-c00d-e053-2995a90ace0cSPL set ID d915dae4-450a-6282-e053-2995a90ab50bRxCUI 1494173UNII 4NRT660KJQ, 70FD1KFU70
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452187054702 followed by a unit qualifier and the quantity

Package 52187-0547-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)